At the end of 2025, the European Union advanced significant initiatives aimed at modernising and strengthening the regulatory framework for the life sciences sector. From the political agreement on the pharmaceutical package that will make wholesale changes to the regulatory framework for medicinal products, making practical changes to the medical devices legislation, and efforts to increase Europe’s competitive edge in biotech, these developments signal a busy period of regulatory reform and…
By: Morgan Lewis
By: Morgan Lewis
